Category

EN

SMIC Announces Second Quarter 2020 Webcast Conference Call

By | EN, PR

SMIC (SEHK: 981, OTCQX: SMICY)

SHANGHAI, July 13, 2020 /PRNewswire/ —

Please join SMIC’s earnings conference call, with:

  • Dr. Zhao Haijun, Co-Chief Executive Officer and Executive Director
  • Dr. Liang Mong Song, Co-Chief Executive Officer and Executive Director
  • Dr. Gao Yonggang, Chief Financial Officer, Executive Director, and Joint Company Secretary
  • Tim Kuo, Director, Investor Relations
    as they announce the company’s second quarter 2020 results and take questions from investors on Friday, August 7, 2020.

The second quarter 2020 results will also be released and available at http://www.smics.com/en/ before the start of trading on the Stock Exchange of Hong Kong on Friday, August 7, 2020.

CONFERENCE CALL / WEBCAST ANNOUNCEMENT DETAILS

DATE: Friday, August 7, 2020
TIME:   8:30 A.M.     (Shanghai and Hong Kong)
             8:30 P.M.     (New York *please note that as this call is live, it will take place on Thursday, August 6th, 2020 EDT)

WEBCAST:

The call will be webcast live with audio at: http://www.smics.com/en/site/company_financialSummary or https://edge.media-server.com/mmc/p/4majjijt

DIAL-IN:

Teleconference call services are affected by the COVID-19, operator assisted conference calls are not available at the moment. You must preregister online in order to receive the dial-in numbers.

ONLINE REGISTRATION:

You may register for the conference call at: http://apac.directeventreg.com/registration/event/1289672

Once preregistration has been complete, you will receive dial-in numbers, the passcode, and a unique registrant ID. To join the conference, dial the number you receive in the email, enter the passcode followed by your registrant ID, and you will join the conference instantly.

REPLAY:

Recording will be available approximately 1 hour after the event and it will be archived for replay at http://www.smics.com/en/site/company_financialSummary, for a period of 12 months following the webcast.

CONTACT:
Investor Relations
+86 21-2081-2804
[email protected]

 

Related Links :

http://www.smics.com

Are you a Corporate Representative of SMIC, an investor, or a member of the Business Press?



Carlsberg Taps Field Service Management Solution From IFS to Brew up Excellence

By | EN, PR

IFS Field Service Management in the cloud to empower 300 Carlsberg field technicians across Europe

LONDON, July 13, 2020 /PRNewswire/ — IFS, the global enterprise applications company, announces that Carlsberg, one of the world’s leading brewery groups, has chosen to deploy IFS Field Service Management™ (FSM) for its European service organization, comprising sites in Denmark, Sweden, Norway, Finland, Poland, and Switzerland during the initial phase.

To ensure the continued growth of its service business, which provides installation, repair and maintenance services to its customers in the hospitality industry, Carlsberg needed a central FSM solution capable of covering all business processes while offering an open and enabled platform for advanced capabilities such as the Internet of Things (IoT).

Following a thorough vendor evaluation process, Carlsberg selected IFS FSM as a managed cloud service to support its field service operations and repair centers. The initial phase will see the solution deployed to field and backoffice staff in Denmark, Sweden, Norway, Finland, Poland, and Switzerland.

"Operational efficiency and visibility are crucially important to us as we are growing our service business and developing our offering," Carlsberg Global Business Solutions Senior Director Per Ahlmann Andersen said. "IFS presented us with a robust field service solution that will give us full control of our assets, whether fielded at customer sites or located in our repair shops and warehouses. Another essential criteria for us was the platform’s ability to scale and flex as our requirements evolve to include new geographies or enabling technologies such as IoT. IFS proved itself as a reliable technology partner wherever our journey takes us."

Elni Kullmer, Managing Director, IFS Nordics, added, "We are very proud to welcome Carlsberg to the IFS community. As we continue to see an increasing number of product-centric businesses turn to service as a way to realize new revenue streams, it is important not to underestimate the importance of a solid enterprise software platform to model, execute, and track these initiatives. In IFS FSM, Carlsberg has selected a market-leading platform that is designed to evolve in lockstep with the business. We look forward to a long and mutually beneficial collaboration. This is a great ‘hopportunity’ for both companies."

IFS Field Service Management will be deployed in the IFS Managed Cloud by global IT services company and Silver-level IFS partner ProV.

Learn more about how IFS supports service organizations at www.ifs.com/corp/industries/service/.

CONTACT:

Lyndsey Rojas
IFS Director of Communications
Phone: +1-888-437-4968
[email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/ifs/r/carlsberg-taps-field-service-management-solution-from-ifs-to-brew-up-excellence,c3146490

The following files are available for download:

 

Related Links :

https://www.ifs.com/

Are you a Corporate Representative of IFS, an investor, or a member of the Business Press?



Kakao Awarded HK$31.2 Million Contract to Future Data’s Korean Subsidiary

By | EN, PR

HONG KONG, July 13, 2020 /PRNewswire/ — GEM listed Future Data Group Limited ("Future Data" or the "Group", 8229.hk), a technology services company, today announced that its wholly own subsidiary Global Telecom Co., Ltd. ("GT", the "Solution Provider") has won a contract to build a new cloud solution for Kakao Corporation ("Kakao", the "Customer"), South Korea’s largest mobile messaging app operator for US$4.0 million (HK$31.2 million).

Following its successful position as South Korea’s largest mobile messaging app, Kakao has ventured into virtual banking business, after receiving a license from the government. The Customer was looking for a solution that provides stable and lowest possible delay for its virtual banking applications over the Internet.

Kakao selected GT’s proposed solution based on Arista Networks technology because the solution provides SDN-based high-performance and high-availability, using VXLAN/EVPN. Kakao’s new IDC aims to provide network services for Kakao Pay, Kakao Game, and Kakao Talk amongst others with stable services and lowest possible delay in the case of Internet traffic congestion and in line with the increase of users. In particular, the Customer focuses on maximizing the utilization of virtualization infrastructure such as OpenStack and Kubernetes (K8s).

GT proposed solution includes network traffic distributed deep buffer switch and Ethernet switch capable of expanding capacity from a 40GE-based infrastructure to a large capacity of 100GE, based on the stability of existing automation systems. The EVPN network also provides flexibility/scalability for automation implementation that integrates Kakao’s Cloud Vision Platform (CVP) and OpenStack as added benefit.

"Kakao has been a long-term Customer of the Group," said David Lee, CEO of the Group. "In the past, we have helped build network infrastructure for Kakao’s mobile messaging app, and extended our relationship to support Kakao’s virtual banking," Mr Lee added.

About Kakao Corporation

Kakao, better known as South Korea’s largest mobile messaging app operator, is an integrated mobile lifestyle platform company with services including mobile messaging (Kakao Talk), gaming (Kakao Games), banking (Kakao bank), music (Melon), e-mail (Daum Mail), search (Daum Search), news (Daum News), and more. With the mission of "Connect Everything", Kakao is dedicated to creating an ecosystem of connectivity where people can stay connected with family and friends by sharing what matters to them.

For more, please visit at www.kakaocorp.com.

About Arista Networks

Arista Networks was founded to pioneer and deliver software-driven cloud networking solutions for large data center storage and computing environments.

For more information, visit www.arista.com.

About Future Data Group Limited

Listed on the GEM Board of the Stock Exchange of Hong Kong Limited in 2016, Future Data is a new breed of technology services companies. Future Data provides a wide range of digital infrastructure and cyber security services to corporate customers. The Group’s distinct competitive advantages include the partnerships and alliances it has forged with a diverse base of leading technology suppliers and the ability to interweave its software development capabilities with a number of these suppliers.

More information can be found at http://www.futuredatagroup.com.

Related Links :

http://www.futuredatagroup.com

Are you a Corporate Representative of Future Data Group Limited, an investor, or a member of the Business Press?



Tencent Music Entertainment Group to Report Second Quarter 2020 Financial Results on August 10, 2020 Eastern Time

By | EN, PR

SHENZHEN, China, July 13, 2020 /PRNewswire/ — Tencent Music Entertainment Group ("Tencent Music", "TME", or the "Company") (NYSE: TME), the leading online music entertainment platform in China, today announced that it will report its unaudited financial results for the second quarter of 2020 after the U.S. market closes on Monday, August 10, 2020.

Tencent Music’s management will hold a conference call on Monday, August 10, 2020, at 8:00 P.M. Eastern Time or 8:00 A.M. Beijing Time on Tuesday, August 11, 2020, to discuss the financial results. Listeners may access the call by dialing the following numbers:

United States Toll Free: 

+1-888-317-6003

International:

+1-412-317-6061

Mainland China Toll Free:

400-120-6115

Hong Kong Toll Free: 

800-963-976

Access Code:

3578903

The replay will be accessible through August 17, 2020, by dialing the following numbers:

United States Toll Free:

+1-877-344-7529

International:

+1-412-317-0088

Access Code:

10146226

A live and archived webcast of the conference call will also be available at the Company’s investor relations website at https://ir.tencentmusic.com/.

About Tencent Music Entertainment

Tencent Music Entertainment Group (NYSE: TME) is the leading online music entertainment platform in China, operating the country’s highly popular and innovative music apps: QQ Music, Kugou Music, Kuwo Music and WeSing. Tencent Music’s mission is to use technology to elevate the role of music in people’s lives by enabling them to create, enjoy, share and interact with music. Tencent Music’s platform comprises online music, online karaoke and music-centric live streaming services, enabling music fans to discover, listen, sing, watch, perform and socialize around music.

For more information, please visit ir.tencentmusic.com.

Investor Relations Contact

Tencent Music Entertainment Group
[email protected]  
+86 (755) 8601-3388 ext.871720

Related Links :

http://ir.tencentmusic.com

Are you a Corporate Representative of Tencent Music Entertainment Group, an investor, or a member of the Business Press?



Trip.com Group Announces Proposed Offering of Up to US$500 Million Exchangeable Senior Notes

By | EN, PR

SHANGHAI, July 13, 2020 /PRNewswire/ — Trip.com Group Limited (Nasdaq: TCOM) ("Trip.com Group" or the "Company"), a leading provider of online travel and related services, including accommodation reservation, transportation ticketing, packaged-tour and in-destination services, corporate travel management, and other travel-related services, today announced that it proposes to offer up to US$500 million in aggregate principal amount of exchangeable senior notes due 2027 (the "Notes") in offshore transactions outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act of 1933, as amended (the "Securities Act") (the "Notes Offering"), subject to market conditions and other factors. Upon exchange, the Company will pay or deliver to such exchanging holders, cash, American depositary shares ("Huazhu ADSs") of Huazhu Group Limited (Nasdaq: HTHT) ("Huazhu"), each representing as of the date of this press release one ordinary share of Huazhu, par value $0.0001 per share, or a combination of cash and Huazhu ADSs, at its election subject to certain conditions. The exchange rate and other terms of the Notes have not been finalized and will be determined at the time of pricing of the Notes Offering.

The Company plans to use the net proceeds from the Notes Offering for general corporate purposes, including repayment of any existing financial indebtedness.

The Notes, the Huazhu ADSs deliverable upon exchange of the Notes, if any, and the ordinary shares of Huazhu represented thereby have not been registered under the Securities Act or any state securities laws. They may not be offered or sold in the United States or to U.S. persons (as defined in Regulation S under the Securities Act) unless the Notes are registered under the Securities Act, or an exemption from the registration requirements of the Securities Act is available.

This press release shall not constitute an offer to sell or a solicitation of an offer to purchase any securities, nor shall there be a sale of the securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.

This press release contains information about the pending Notes Offering, and there can be no assurance that the Notes Offering will be completed.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "may," "will," "expect," "anticipate," "future," "intend," "plan," "believe," "estimate," "is/are likely to," "confident" or other similar statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Potential risks and uncertainties include, but are not limited to, severe or prolonged downturn in the global or Chinese economy, general declines or disruptions in the travel industry, volatility in the trading price of Trip.com Group’s ADSs, Trip.com Group’s reliance on its relationships and contractual arrangements with travel suppliers and strategic alliances, failure to compete against new and existing competitors, failure to successfully manage current growth and potential future growth, risks associated with any strategic investments or acquisitions, seasonality in the travel industry in the relevant jurisdictions where Trip.com Group operates, failure to successfully develop Trip.com Group’s existing or future business lines, damage to or failure of Trip.com Group’s infrastructure and technology, loss of services of Trip.com Group’s key executives, adverse changes in economic and political policies of the PRC government, inflation in China, risks and uncertainties associated with PRC laws and regulations with respect to the ownership structure of Trip.com Group’s affiliated Chinese entities and the contractual arrangements among Trip.com Group, its affiliated Chinese entities and their shareholders, and other risks outlined in Trip.com Group’s filings with the U.S. Securities and Exchange Commission. All information provided in this press release and in any attachments is as of the date of the issuance, and Trip.com Group does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

About Trip.com Group Limited

Trip.com Group Limited (Nasdaq: TCOM) is a leading one-stop travel service provider consisting of Trip.com, Ctrip, Skyscanner, and Qunar. Across its platforms, Trip.com Group enables local partners and travelers around the world to make informed and cost-effective bookings for travel products and services, through aggregation of comprehensive travel-related information and resources, and an advanced transaction platform consisting of mobile apps, Internet websites, and 24/7 customer service centers. Founded in 1999 and listed on Nasdaq in 2003, Trip.com Group has become one of the largest travel companies in the world in terms of gross merchandise value.

Related Links :

https://www.ctrip.com/

Are you a Corporate Representative of Trip.com Group Limited, an investor, or a member of the Business Press?



Oriental Yuhong Obtains an Invention Patent in Singapore after One in the US

By | EN, PR

BEIJING, July 12, 2020 /PRNewswire/ — Oriental Yuhong’s product – HDPE polymer waterproof coiled material – has recently obtained a patent (patent NO. 11201705060T) issued by the Intellectual Property Office of Singapore. Last year, its product of the same series was granted a patent (patent NO. 11201705060T) by the IP Australia and a patent by the United States Patent and Trademark Office (patent NO. US10487215).

Patent application
Patent application

In 2019, Oriental Yuhong broke the European and American monopoly and participated in the construction of a subway in Singapore. The subway – ThomsonLine – is 30 kilometers long. In order to solve the problem of underground leakage, Oriental Yuhong provided a professional waterproof solution and adopted HDPE self-adhesive film waterproof coiled material for waterproof construction. Due to the regional requirements and protection of the product patent, Oriental Yuhong applied for a patent on its HDPE product in Singapore in advance. The high-performance, multi-material, multi-layer waterproof protection technology for underground waterproof protection with this patent as the core solves the bottleneck problem of water leakage of traditional waterproof protection technology, promotes the progress of underground waterproof protection technology, and enhances Oriental Yuhong’s international technological competitiveness. The technology won a class-II prize in the National Award for Scientific and Technological Progress in 2019.

The HDPE products are suitable for all kinds of underground waterproof projects. Projects at home and abroad over the past 30 years have showed that Oriental Yuhong’s HDPE polymer self-adhesive film waterproof coiled material and underground pre-laying anti-adhesive waterproof construction technology, which are suitable for most of the underground spaces – subways, tunnels, pipe corridors, nuclear power and other fields – have been used in projects like South-to-North Water Diversion, Liupanshui Underground Comprehensive Pipe Corridor, Beijing-Shanghai High-Speed Railway and Beijing-Kaifeng Subway, and have been exported to the US, India, Singapore, Malaysia, Indonesia and other foreign countries, have been recognized by more and more customers. With 1 million square meters of waterproof materials sold internationally every year, Oriental Yuhong is getting more and more recognition and attention.

Oriental Yuhong always regards scientific and technological innovation as its core competitiveness and attaches great importance to intellectual property protection. It will also apply for patents on its HDPE products in other countries. As of July 1, the Group has totally had 957 valid patents (including 291 inventions, 553 utility models and 113 designs), and 12 PCT international applications.

Related Links :

http://www.yuhong.com.cn

Are you a Corporate Representative of Beijing Oriental Yuhong Waterproof Technology Co., Ltd., an investor, or a member of the Business Press?



Sales of Cardio-Cerebrovascular Products and Lianhua Qingwen Surge, Yiling Pharmaceutical Predicting a 50% Increase in Half-year Net Profit

By | EN, PR

SHIJIAZHUANG, China, July 13, 2020 /PRNewswire/ — In the evening of July 12, Yiling Pharmaceutical released the performance forecast for the first half year. In the first half of this year, the company achieved a net profit attributable to shareholders of 682 million to 728 million Yuan (USD 97.4 million to 104 million), an annual increase of 50%-60%, with basic earnings of 0.57 – 0.60 Yuan per share, and the strong growth momentum of the first quarter persists.

In 2019 Yiling Pharmaceutical achieved a net profit of 606.5 million Yuan. The net profit of the first half in this year already exceeds that of the whole year last year.

According to Yiling Pharmaceutical, there are two main reasons accounting for the surge in revenue: On the one hand, sales revenue of Lianhua Qingwen in the first half of this year saw a rapid growth compared with the same period last year. Lianhua Qingwen has also experienced a remarkable year-over-year rise in sales in the second quarter as the popularity and reputation of the product advance at home and abroad. On the other hand, the outbreak of COVID-19 was well contained in the second quarter, coupled with the fact that the company was granted the First Prize of China’s National Science and Technology Progress, which has greatly enhanced the influence of the company on the market of cardio-cerebrovascular products. The sales revenue of these products achieved growth in the second quarter.

The Second Quarter Performance Exceeds Market Expectations

Yiling Pharmaceutical’s performance forecast of the first-half of this year has attracted widespread attention in the market. Due to COVID-19, it was generally believed that the growth rate in the first quarter would serve as the peak of this year’s growth. With the domestic outbreak well under control in the second quarter, the company’s growth rate would go downward quarter by quarter, but according to the company’s performance forecast of the first half year, the growth rate in the second quarter could very likely be surpassing that of the first quarter, which exceeds the market expectations.

The published statistics show that in the first quarter of this year, Yiling Pharmaceutical achieved an operating revenue of 2.334 billion Yuan, a year-on-year increase of 50.56%. The net profit attributed to shareholders was 437 million Yuan, up by 51.88% year-on-year.

"Judging from the trend of net profit of Yiling Pharmaceutical in recent years, it is estimated that the revenue growth rate in the second quarter should also be more than 50%, with which the company will further consolidate its leading position in the traditional Chinese medicine industry", said a brokerage analyst.

At the end of the first half year of 2020, the financial data company Wind released a list of "Top 500 Publicly Traded Chinese Companies for the First Half Year 2020". The statistics were collected until June 30. The entry threshold of the list this year was risen to 31.2 billion Yuan, an increase of 5.1 billion Yuan compared with 26.1 billion Yuan in the first quarter. Yiling Pharmaceutical made the list with a market value of 37.5 billion Yuan, an increase of 150% in market value, moving up 583 places in the ranking.

Cardiovascular Product Sales Growing Against the Market Trend

In addition to the Lianhua Qingwen boom, sales revenue of cardiovascular products of Yiling Pharmaceutical has also been climbing against the market trend in the second quarter, which is also worthy of attention. Although the coronavirus outbreak was already tamed during the second quarter, yet the number of outpatient visits to most hospitals hadn’t return to the previous years’ level in the same period of time due to precautionary measures concerning COVID-19 and other factors. According to the "Investigation of the Operating State of Chinese Social Medical Institutions during the Outbreak of COVID-19 in 2020", jointly conducted by the Medical Management Research Center of "Medical Industry Observe" and the Institute of Social Medical Institutions of Shanghai Jiaotong University, only 6.6% of the sample hospitals had a number of outpatient visits till May comparable or higher than that in the same period last year; 36.9% of the hospitals resumed more than 80% of the outpatient visits of that in the same period last year; and more than 30% of the hospitals failed to recover even 50% of the figure in the same period last year.

The decline in outpatient visits led directly to a decrease in sales revenue for the majority of drugs compared to the same period last year, while the sales of Yiling Pharmaceutical’s cardio-cerebrovascular products in the second quarter went up, the driving force of which can mainly be attributed to the awarding of the First Prize of National Science and Technology Progress. In January this year, the research project "Establishment of a Theoretical Framework of Meridians in TCM and Guidance for Prevention and Treatment of Microangiopathy" with Research Institute of Yiling Pharmaceutical in Hebei Province, a subsidiary of Yiling Pharmaceutical, as the major research institution won the First Prize of National Science and Technology Progress in 2019, which was the only project in medical and health sector awarded First Prize in that year.

Publicly available information reveals that the project conducted numerous clinical trials adopting the internationally recognized evidence-based research method and successfully resolved a huge international medical challenge: With Tongxinluo Capsule the world medical obstacle of no-reflow in patients with acute myocardial infarction was overcome; Shensong Yangxin Capsule provides a new drug for the treatment of heart failure (CHF) patients with premature ventricular contraction (PVC), filling the gap of drug treatment of sinus bradycardia with ventricular premature beats to achieve a coordinated rhythm; Qi Li Qiang Xin Capsule significantly improved the effect of clinical treatment of chronic heart failure. Having obtained this award has notably increased the market influence of the company’s cardio-cerebrovascular products, thereby driving the sales of related products in the second quarter.

In addition, the positive impact of the First Prize of the National Science and Technology Progress Award on the company’s cardio-cerebrovascular products continues. The recently published "Chinese Expert Consensus 2020 for Ventricular Arrhythmia", jointly compiled by the Electrophysiology and Pacing Branch of Chinese Medical Association and the Professional Committee on Rhythmology of Chinese Medical Doctor Association, recommends the use of Shensong Yangxin Capsules in treating non-organic premature ventricular contractions (PVCs), organic ventricular premature beats, heart failure with ventricular premature beats, sinus bradycardia with ventricular premature beats, and the level of evidence was upgraded to Level A, which helped to further open up the market for Shensong Yangxin Capsules.

In the Post-Epidemic Period, the Sales of Lianhua Qingwen also Increased Substantially

During the pandemic outbreak of coronavirus disease, the "Three Drugs and Three Prescriptions" including Lianhua Qingwen were widely embraced by the public and glinted brightly on the market. A few days ago, a white paper titled "Fighting COVID-19: China in Action." released by the State Council clearly points out that Lianhua Qingwen and other traditional Chinese medicine show definite clinical effects. Lianhua Qingwen is listed as a recommended drug to treat COVID-19 and an approval was given adding COVID-19 to its indications. A clinical study regarding effects of Lianhua Qingwen in treating COVID-19 conducted by academicians such as Zhong Nanshan, Li Lanjuan and Zhang Boli and 23 hospitals confirms that the drug is safe and effective, which was published in an authoritative international journal. In the first quarter of this year, Lianhua Qingwen achieved an operating revenue of 1.542 billion Yuan with an almost doubled year-on-year increase.

According to the performance forecast for the first half of the year, sales volume of Lianhua Qingwen showed a significant year-on-year growth, even when the domestic coronavirus outbreak was under control in the second quarter. A stock analyst, who wishes to remain anonymous, said that the strong growth of Lianhua Qingwen in the second quarter had, to a certain extent, revealed that this drug had become a commonly used drug in China. With Lianhua Qingwen’s increasing popularity in the domestic market, its market share in traditional indications such as influenza and cold is expected to expand, which will lead to stronger growth in sales. In the meantime, Lianhua Qingwen was approved in 9 countries and regions including Brazil, Romania, Ecuador, Singapore, etc., as well as Hong Kong and Macau in China, opening up overseas markets with a breakthrough.

While achieving good performance in revenue, the investment value of Yiling Pharmaceutical has also been widely recognized by many institutions. Tianfeng Securities believes that as various sectors of the company such as Chinese medicine, chemical medicine, healthcare, etc., continue to develop and the process of globalization is steadily pushed forward, they are optimistic about the future of the company. Dongxing Securities has indicated in their latest research report that the increase in the popularity of Lianhua Qingwen during the coronavirus outbreak and the expansion of indications could help to further open up rooms for more sales volume. Support from Evidence-based medicine and expansion to grassroots markets could also promote steady growths of other core products, hence a rating of "recommended" is granted.

 

Are you a Corporate Representative of Yiling Pharmaceutical Co, Ltd., an investor, or a member of the Business Press?



Amorepacific Group Launches Its Luxury Beauty Brand Sulwhasoo Across India With Nykaa

By | EN, PR

– Amorepacific Group expands its brand portfolio in India by launching Sulwhasoo with Nykaa

– Sulwhasoo to present its unique vision of ageless beauty inspired by timeless wisdom to Indian customers through its innovative skincare range

SEOUL, South Korea, July 13, 2020 /PRNewswire/ — Global beauty company, Amorepacific Group (hereafter, Amorepacific) announced today the launch of Sulwhasoo in India.

Sulwhasoo First Care Activating Serum
Sulwhasoo First Care Activating Serum

In a bid to further its inroads into the Indian market, Amorepacific – the largest beauty company in Korea – launched its luxury beauty brand Sulwhasoo in India exclusively with Nykaa. Prior to the current Sulwhasoo launch, Amorepacific has launched its beauty brands such as innisfree in 2013, Laneige in 2018 and Etude in 2019 in India.

Sulwhasoo is Amorepacific’s signature luxury brand. 50 years of dedicated research on legendary Korean Ginseng and rare element from the scarce plant, Sulwhasoo formulates innovative skin solution by infusing wisdom and modern science, awake skin’s radiance that is from confidence with healthy glow.

Sulwhasoo Concentrated Ginseng Renewing Cream
Sulwhasoo Concentrated Ginseng Renewing Cream

Sulwhasoo is set to spread its vision of ageless beauty inspired by timeless wisdom to the Indian market through Nykaa, the leading omni-channel beauty retailer in India. The Pan India market will be covered by the online launch of the brand from July 13, 2020. In addition, Nykaa Luxe store launch is planned for mid-August in Delhi and end of 2020 in Mumbai. The offerings in the Indian Market boasts of the brand’s star product, First Care Activating Serum (1 bottle of this product is sold every 10 seconds in Korea) and other signature products such as Concentrated Ginseng Renewing line and Essential line, to name a few. The details of Sulwhasoo’s two hero products are as follows:

First Care Activating Serum: Launched in 1997 to inaugurate the boosting serum category, Sulwhasoo’s First Care Activating Serum contains JAUM Balancing Complex™, which combines five ingredients carefully selected from 3,000 herbs in traditional Korean medicine. The Sacred Lotus, Peony, Solomon’s Seal, White Lily and Rehmannia makeup up the trademarked JAUM Balancing Complex™ in this serum. The product, to be used as a first-step of skincare after washing, effectively achieves the skin balance to give a radiant glow.

Concentrated Ginseng Renewing Cream: Sulwhasoo has invested in 50 years of research in order to transform the legendary ginseng ingredient into an innovative skincare solution. Sulwhasoo has made a scientific breakthrough by studying not just the ginseng root that has been recognized for its exceptional efficacies, but also its leaves, stems, flowers and berries that others have overlooked. The pinnacle of this is the Sulwhasoo’s Concentrated Gingseng Renewing Cream, which works as a potent anti-aging cream.

"We are delighted to introduce Amorepacific’s signature brand, Sulwhasoo, in India. While Innisfree, Laneige and Etude brands are running active on Nykaa, a leading retailer in the Indian beauty market, we are pleased adding Sulwhasoo that will bring luxury skincare to our Indian consumers – with over 50 years of experience in the brand history. I believe our customers in India are going to experience Sulwhasoo’s unique beauty solutions and to create more sophisticated and healthier skincare routines in future," said Michael Youngsoo Kim, Head of Amorepacific APAC RHQ.

"In recent years, Nykaa has led the Korean beauty conversation in India, focusing on educating Indian customers on the novelty of the products and ingredients. This has resulted in an incremental growth of the skincare category as our customers become more demanding and discerning about their choices. We are very excited to launch Sulwhasoo in India with its unique and innovative solutions which are sure to delight our customers," said Falguni Nayar, Founder & CEO of Nykaa.

As a leading global beauty company, Amorepacific furthered the popularity of Asian Beauty across the globe with its 74-year legacy and innovative, customer-centric technologies. Ranked in Forbes’ list of the World’s 100 Most Innovative Companies for four consecutive years, the company has transformed daily skincare routines across the globe through category innovations such Boosting Serums, Sleeping Masks and Cushion Compacts, which have disrupted the global beauty market.

About Amorepacific

Since 1945, Amorepacific has had a single, clear mission: to present its unique perception of beauty– namely what it calls ‘Asian Beauty’ – to the world. As Korea’s leading Beauty Company, Amorepacific draws from its deep understanding of both nature and human to pursue harmony between inner and outer beauty. With its portfolio of over 20 cosmetics, personal care, and health care brands, Amorepacific is devoted to meeting the various lifestyles and needs of global consumers around the world: Asia, North America, Europe, Oceania and the Middle East. Amorepacific’s research hubs located around the world are dedicated to sustainable R&D that combine the best of natural Asian ingredients and advanced bio-technology. With its world-class products, Amorepacific is acclaimed for the innovative ways in which it is transforming global beauty trends. https://www.apgroup.com/int/en/index.html

About Sulwhasoo Brand

In the year of 1966, Sulwhasoo’s originator Suh Sung-Whan placed the resolution to develop cosmetic products with ginseng led to the creation of the cosmetics that was the beginning of Sulwhasoo today. Ever since the start of the brand, Sulwhasoo believes that the beauty does not deteriorate over time, instead it evolves. To encourage women be confident with healthy glow at every milestone in life, Sulwhasoo Heritage and Science Centre conducted research over 50 years on not only the Korean Ginseng, but also all 3,912 complex of traditional herbs recorded in ancient Asian medical texts, with in-depth research on women’s skin of all ages. Sulwhasoo awake your radiance that is from confidence with healthy glow, by infusing wisdom with modern science. https://www.sulwhasoo.com/int/en/index.html

About Nykaa

Founded in 2012 by Indian entrepreneur Ms. Falguni Nayar, Nykaa was created with a vision of providing a carefully curated range of products for every beauty solution. Derived from the Sanskrit word ‘Nayaka’ meaning one in the spotlight, it rests on three ideals – curation, content and convenience. Nykaa currently has a portfolio of 1500+ brands across makeup, skincare, haircare & wellness offering a one-stop, personalized product availability and solutions to consumers across India. The Nykaa website and app welcome over 60 million visits per month, of which 80% are loyal repeat customers. Nykaa has created an engaged community of beauty enthusiasts across India, emerging as a leading beauty influencer through conversations on social media, emails, videos and beauty blog. The retailer currently has 68 stores across the country in two formats – Nykaa Luxe and Nykaa On Trend. https://www.nykaa.com/

Photo – https://photos.prnasia.com/prnh/20200701/2844965-1?lang=0
Photo – https://photos.prnasia.com/prnh/20200709/2844965-1-b?lang=0

 

Related Links :

https://www.apgroup.com/int/en

Are you a Corporate Representative of Amorepacific, an investor, or a member of the Business Press?



Cromwell Property Group and Cromwell European REIT Partner with EXS and Stratus for New Data Centre Property Platform

By | EN, PR

SYDNEY, July 13, 2020 /PRNewswire/ — Diversified real estate investor and manager Cromwell Property Group (ASX:CMW) (Cromwell) has entered into a strategic partnership with Stratus Data Centres (Stratus), a member of the EXS Capital Group (EXS), to invest in and manage the rollout of a data centre property platform across Europe and Asia Pacific through the new Stratus Cromwell Data Centre Fund (SCDC Fund or the Fund).

This highly complementary partnership will combine the data centre sector specialisation of Stratus, who will be responsible for project development, leasing, design and construction, with the Asian network of EXS and Cromwell’s capital, funds management and real estate investment experience.

Cromwell will be a cornerstone investor in the SCDC Fund which is targeting an eventual gross asset value of over US$1 billion, with 25% of the portfolio already identified by the first two strategic sites under exclusivity. Cromwell will also source investment funding and subsequently provide joint fund management and asset management services upon the completion of each project.

Simultaneously, Cromwell European Real Estate Investment Trust (SGX:CNNU; CSFU) (Cromwell European REIT or CEREIT) has entered into a Heads of Term Agreement with Stratus and Cromwell to co-invest directly into 50% stakes in the SCDC Fund’s first two data centre projects in London and Frankfurt, subject to various milestones.

The first project is a two-stage, 100 megawatt (MW) data centre serving London. The 6-acre project site is well-located on fibre optic routes in the east of the city, will be powered by renewable energy and negotiations with potential tenant operators are well advanced. Construction is expected to be completed in 2021.

The second, larger project is on a 34-acre strategic site serving Frankfurt. A multi-stage 300MW project, with advanced pre-leasing agreements and planning processes underway, once completed it will be one of the largest data centre campuses in Germany and Western Europe. 

The exponential growth of data created by social media, mobile devices, video streaming and cloud computing has driven unprecedented demand for data centres. This demand has only been accelerated by the COVID-19 pandemic pushing more of modern life and business online. With strong real estate asset backing and long-term leases against world class cloud operators, data centre properties can provide investors with stable income, downside protection and strong potential upside.

Cromwell’s Chief Investment Officer, Rob Percy said: "The partnership is another good example of our ‘Invest to Manage’ strategy in operation. We are delighted to be able to partner with a specialist organisation of Stratus’ calibre to create an exciting investment opportunity that we know will be in strong demand from both leading hyperscale data centre operators and international capital partners."

Simon Garing, CEO of the Manager of CEREIT said: "We have identified a sector with significant investment opportunity in Europe, where we believe there will be continued demand for data centre projects. Data centres are a natural fit to our existing investment strategy and portfolio composition and we expect to realise attractive risk adjusted returns for CEREIT unitholders from the partnership. The platform will also allow us to extract additional value through a number of potential future data centre opportunities in strategic locations within CEREIT’s existing 1.4 million sqm portfolio."

Eric Solberg, Chairman of Stratus and EXS, commented: "We are delighted to combine our development and data centre expertise in international markets with Cromwell’s capital, funds management and real estate investment experience."

"The London and Frankfurt projects are just the beginning, with further projects identified in key gateway cities in Europe including Dublin and Milan, and in Asia, including Tokyo, Manila, Jakarta and Mumbai. As a specialist ‘developer of developers’ in Asian real estate, EXS is excited to bring our network of regional local partners to the SCDC Fund."

Nigel Clarkson, CEO of Stratus, added: "As a twenty-year plus veteran developing and converting data centes across the UK, Europe, Asia and Australia, I can say that global demand for cloud computing is only going one way — up! With Cromwell’s support, we will look to accelerate the development of our global data centre property portfolio and even better serve our hyperscale and cloud operator tenants and partners."

ABOUT CROMWELL PROPERTY GROUP

Cromwell Property Group (ASX:CMW) is a diversified real estate investor and manager with operations on three continents and a global investor base. As at 31 December 2019, Cromwell had a market capitalisation of $3.1 billion, a direct property investment portfolio valued at $3.2 billion and total assets under management of $11.9 billion across Australia, New Zealand and Europe.

ABOUT CROMWELL EUROPEAN REIT

Cromwell European REIT is a real estate investment trust with the principal investment strategy of investing, directly or indirectly, in a diversified portfolio of income-producing real estate assets in Europe that are used primarily for office, light industrial / logistics, and retail purposes.

CEREIT’s portfolio comprises 94 primarily freehold or ongoing leasehold properties in or close to major gateway cities in Denmark, Finland, France, Germany, Italy, the Netherlands and Poland, with a balanced focus on the office and light industrial / logistics sectors. As at 31 March 2020, CEREIT’s portfolio had an appraised value of approximately EUR2,075[1] million and an aggregate lettable area of approximately 1.4 million square metres with close to 800 tenant-customers and a WALE profile of around 4.5 years.

CEREIT is the first REIT with a diversified Pan-European portfolio to be listed on the Singapore Exchange Securities Trading Limited. CEREIT is managed by Cromwell EREIT Management Pte. Ltd., a wholly-owned subsidiary of CEREIT’s Sponsor, Cromwell Property Group.

ABOUT STRATUS DATA CENTRES

Stratus is an independent data centre (DC) property platform, led and managed by an experienced, specialist management team, which has over 20 years of proven track record in DC property investments, development and management. Stratus has worked with a number of global investors to identify and secure exclusive access to DC projects and tenants through existing relationships.

Stratus provides comprehensive products that meet tenants’ needs, such as Powered & Planned Shell, Fully-fitted, and turnkey solutions. Stratus is not a DC operator and does not compete with tenants in colocation business. Stratus aims to be the long-term property partner of its customers, who can leverage its expertise in sourcing sites outside their home markets, securing power and planning, and developing build-to-suit DCs in multiple locations across Asia & Europe, achieving true "resource augmentation" for global hyperscale and cloud operators.

ABOUT EXS CAPITAL

EXS is an independent private equity real estate investment firm with offices in the Cayman Islands, Hong Kong and Singapore and led by Eric Solberg, a 30-year Asia investment veteran and a pedigree team. Over the past decade, EXS has led over US$1 billion of completed and ongoing investments across Asia and related markets.

EXS sponsors private equity style investments into real estate businesses in partnership with expert management, either local developers or sector specialists, with the goal of building high-valuation market leaders. EXS’ highly differentiated strategy and fund structure allows closer long-term partnership with management, counter-cyclical multi-stage investments and ultimately higher expected realizations and returns.

Various members of the EXS Capital Group are licensed in Singapore with the MAS in Singapore for Fund Management; in Hong Kong with the Securities & Futures Commission in Hong Kong for Advisory, Corporate Finance and Asset Management, the Hong Kong Estates Agents Authority for Real Estate; and with CIMA in the Cayman Islands.

[1] Valuation is based on independent valuations conducted by Colliers and Cushman & Wakefield as at 31 December 2019 for 91 existing properties in the portfolio. The three assets acquired in Germany with completion on 24 March 2020 are being carried at their purchase price.

 

Are you a Corporate Representative of Cromwell Property Group, an investor, or a member of the Business Press?



Trinseo Announces its 2030 Sustainability Goals

By | EN, PR

Fifteen sustainability goals outline the Company’s focus on climate change, product portfolio, supplier and operational responsibility, and a sustainable workforce

HONG KONG, July 13, 2020 /PRNewswire/ — Trinseo (NYSE: TSE), a leading solution provider, today announced its 2030 Sustainability Goals. Reaching a milestone celebrating its 10th anniversary this year, Trinseo believes it is high time to embark on an ambitious, measurable, and achievable longer-term sustainability journey.

Trinseo Announces its 2030 Sustainability Goals
Trinseo Announces its 2030 Sustainability Goals

"We are proud to announce Trinseo’s Sustainability Goals for the next decade that will drive long-term, positive change for our organization, our customers, this generation, and the next," said Frank Bozich, President and Chief Executive Officer, Trinseo. "Our commitment to sustainability is embedded into our company culture through our operations and our commitment to deliver innovative and sustainable technologies. By partnering with like-minded customers, suppliers and other stakeholders, we are creating sustainable changes."

This ambitious plan includes 15 long-term goals under five main categories that target climate change, sustainable products, supplier responsibility, responsible operations, and sustainable workforce. These goals were created, in part, from a critical assessment of the Company’s capabilities as well as valuable feedback from customers and suppliers.

"Given the many challenges our industry and society face, we believe that we must strive to be a driver of sustainable solutions," said Walter van het Hof, Global Industry Affairs & Sustainability Leader, Trinseo. "We have a responsibility as a company to contribute to making the world a better place, by solving significant problems with our technologies and promoting a culture that is true to our core values."

Using inspiration from the United Nations Sustainable Development Goals (SDGs) and the Global Reporting Initiative (GRI) framework for sustainability reporting, Trinseo has committed to taking a deeper and more holistic look at its material topics and related impacts, based on the priorities of its stakeholders. Through that analysis, the Company is setting a foundation to drive meaningful change across all areas of business.

At a glance, the five main categories of the sustainability goals include:

Climate Change

  • By 2035, reduce 1 & 2 GHG emissions intensity by 35% Scope with progress milestones of 10% reduction by 2025 and 20% reduction by 2030.
  • By 2030, increase the share of electricity from non-fossil sources from 5% to 30%.

Sustainable Products

  • By 2025, dedicate at least 30% of technology and innovation/R&D efforts toward circular economy solutions.
  • By 2030, increase the share of sustainably advantaged products to 40%.

Supplier Responsibility

  • By 2025, implement a Sustainability/Corporate Social Responsibility (CSR) Due Diligence program for new key suppliers as an addition to the existing supplier on-boarding process.

Responsible Operations

  • By 2030, reduce freshwater intake by 20%, overall waste generation by 15% and waste disposal to landfill to zero.
  • By 2030, all pellet-handling sites achieve zero pellet loss to the environment through Operation Clean Sweep®.

Sustainable Workforce

  • Continuously meet societal expectations to live out our values of safety, respect for people, and employee engagement.

View all 15 Sustainability Goals at trinseo.com/sustainabilitygoals

Trinseo’s Sustainability program was recognized by Newsweek in its list of America’s Most Responsible Companies 2020 (ranked #5 in the Materials industry) as well as receiving positive ratings from EcoVadis and CDP (formerly known as the Carbon Disclosure Project).

About Trinseo

Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber. We are focused on delivering innovative and sustainable solutions to help our customers create products that touch lives every day — products that are intrinsic to how we live our lives — across a wide range of end-markets, including automotive, consumer electronics, appliances, medical devices, lighting, electrical, carpet, paper and board, building and construction, and tires. Trinseo had approximately US$3.8 billion in net sales in 2019, with 17 manufacturing sites around the world, and approximately 2,700 employees. For more information visit www.trinseo.com.

Cautionary Note on Forward-Looking Statements

This press release may contain "forward-looking statements" including, without limitation, statements concerning plans, objectives, goals, projections, expectations, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts. Forward-looking statements may be identified by the use of words like "expect," "estimate," "will," "may," or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on the Company’s current expectations and assumptions regarding the impact from the COVID-19 pandemic, the Company’s business, the economy and other future conditions. Specific factors that could cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, risks related to the ongoing impact of the COVID-19 pandemic and those discussed in the Company’s Annual Report for the year ended December 31, 2019 filed with the Securities and Exchange Commission ("SEC"), in subsequent Quarterly Reports on Form 10-Q and in other filings and furnishings made by the Company with the SEC from time to time. Other unknown or unpredictable factors could also have material adverse effects on the Company’s performance. As a result of these or other factors, the Company’s actual results may differ materially from those contemplated by the forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof and are not a guarantee of future performance. The Company undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Press Contact:

Trinseo

Mandy Markert

+41 44 718 3635

Photo – https://photos.prnasia.com/prnh/20200709/2853840-1?lang=0

Related Links :

http://www.trinseo.com

Are you a Corporate Representative of Trinseo, an investor, or a member of the Business Press?